Nectar Lifesciences Limited (NSE:NECLIFE)

Nectar Lifesciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 22, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	2,840	5,147	6,761	3,577	5,393	4,171
Market Cap Growth	-67.85%	-23.88%	89.03%	-33.68%	29.30%	89.80%
Enterprise Value	7,364	11,251	13,371	11,331	14,300	11,065
Last Close Price	14.62	22.95	30.15	15.95	24.05	18.60
PE Ratio	-	-	135.37	-	21.53	-
PS Ratio	0.17	0.31	0.40	0.24	0.32	0.27
PB Ratio	0.40	0.54	0.63	0.34	0.50	0.39
P/TBV Ratio	0.40	0.57	0.67	0.35	0.52	0.41
P/FCF Ratio	-	4.10	3.46	3.45	7.70	-
P/OCF Ratio	-	3.04	3.01	2.68	5.68	19.51
EV/Sales Ratio	0.44	0.67	0.79	0.74	0.86	0.72
EV/EBITDA Ratio	-	-	8.71	21.00	9.02	10.04
EV/EBIT Ratio	-	-	14.40	-	14.08	22.14
EV/FCF Ratio	-	8.95	6.85	10.94	20.42	-
Debt / Equity Ratio	0.64	0.61	0.59	0.71	0.79	0.85
Debt / EBITDA Ratio	-	-	4.14	13.97	5.42	8.19
Debt / FCF Ratio	-	4.63	3.26	7.28	12.28	-
Asset Turnover	-	0.79	0.77	0.67	0.70	0.62
Inventory Turnover	-	1.83	1.62	1.60	1.78	1.39
Quick Ratio	-	0.40	0.45	0.41	0.53	0.38
Current Ratio	-	1.21	1.32	1.38	1.35	1.04
Return on Equity (ROE)	-	-11.23%	0.47%	-2.25%	2.33%	-6.67%
Return on Assets (ROA)	-	-2.61%	2.65%	-0.14%	2.66%	1.24%
Return on Invested Capital (ROIC)	-7.73%	-5.52%	1.46%	-0.28%	3.86%	2.61%
Return on Capital Employed (ROCE)	-	-8.60%	7.60%	-0.40%	7.30%	4.20%
Earnings Yield	-125.02%	-22.09%	0.74%	-6.76%	4.64%	-17.56%
FCF Yield	-	24.41%	28.88%	28.96%	12.98%	-2.36%
Total Shareholder Return	1.69%	-	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.